Josh Schimmer
Stock Analyst at Evercore ISI Group
(5)
Main Sectors:
Top Industries:
62 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RNA Avidity Biosciences | Maintains: Outperform | 70 65 | 46.97 | 38.39% | 6 | Sep 22, 2025 | |
CGON CG Oncology | Reiterates: Overweight | 75 75 | 39.82 | 88.35% | 5 | Sep 8, 2025 | |
DNLI Denali Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 3 | Sep 8, 2025 | |
SEPN Septerna | Reiterates: Overweight | 25 25 | 20.68 | 20.89% | 4 | Sep 5, 2025 | |
CABA Cabaletta Bio | Reiterates: Overweight | 15 15 | 2.44 | 514.75% | 2 | Sep 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 8 | 3.15 | 153.97% | 7 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 95 95 | 52.86 | 79.72% | 12 | Jul 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 25 | 9.88 | 153.04% | 1 | Jul 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 6 | 6.43 | -6.69% | 2 | Jun 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 260 280 | 204.05 | 37.22% | 4 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 50 50 | 16.08 | 210.95% | 2 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 20 | 2.95 | 577.97% | 2 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 215 | 183.36 | 17.26% | 5 | Feb 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 5 5 | 2.05 | 143.9% | 4 | Dec 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 200 200 | 24 | 733.33% | 6 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 47.9 | -47.81% | 1 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 16 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 30 30 | 10.31 | 190.98% | 4 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 2 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 90 90 | 40.86 | 120.26% | 6 | Sep 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 15 | 0.56 | 2578.57% | 3 | Aug 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 65 65 | 39.61 | 64.1% | 3 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 60 | 72.95 | -17.75% | 5 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 43 5 | 3.6 | 38.89% | 2 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 40 | n/a | n/a | 1 | Jun 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 11 | 2.42 | 354.55% | 2 | Jun 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 24 15 | n/a | n/a | 3 | Apr 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 2 2 | n/a | n/a | 1 | Mar 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 140 130 | 137.03 | -5.13% | 1 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 760 | 600 | 26.67% | 2 | Oct 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 15 | 16.94 | -11.45% | 1 | Mar 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | n/a | n/a | 1 | Aug 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 350 | n/a | n/a | 1 | Jun 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | n/a | n/a | 1 | Mar 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 55 | 5.9 | 832.2% | 1 | Feb 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 1.75 | 1614.29% | 1 | Dec 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 480 | n/a | n/a | 1 | Sep 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 15 | n/a | n/a | 3 | May 12, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | n/a | n/a | n/a | 4 | Dec 9, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 2 | Apr 12, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 3 | Feb 25, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 222 250 | 443.01 | -43.57% | 4 | Nov 16, 2018 |